CL · Colgate Palmolive Co
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Jul 31, 2026TL;DR. Colgate delivered Q2 organic sales growth of 2.4%, Base Business EPS up 8% to $0.99, and 140 bps gross margin expansion, while raising full-year gross margin and Base Business EPS guidance; however, GAAP EPS fell 5% to $0.86 on Strategic Growth and Productivity Program charges, North America sales declined 3.0% with the CEO stating he was 'not satisfied' with U.S. performance, and the top-line sales and GAAP EPS guidance ranges were maintained rather than raised.
- + Raised full-year Base Business EPS outlook to mid-single-digit growth (from low- to mid-single-digit) and gross margin to roughly flat (from down).
- + Free cash flow before dividends rose to $1,476M from $1,252M, with CEO citing free cash flow up 18% YTD.
- + Broad-based international growth led by Latin America organic sales +5.3%, Asia Pacific organic +5.2%, and emerging markets organic +4.8%, with India up double-digits and Brazil up high single digits.
- − North America net sales declined 3.0% with organic volume down 3.9%, and the CEO said he was 'not satisfied' with U.S. performance.
- − Company expects higher raw materials and tariffs in the second half than in Q2, with COGS and tariffs expected to peak in the back half of the year.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CL
this stock
Colgate Palmolive Co
|
$69.13B | +9.4% | +1.7% | 34.3 | 2.3% |
|
PG
PROCTER & GAMBLE Co
|
$339.90B | +3.5% | +3.3% | 22.1 | 1.0% |
|
UL
Unilever PLC
|
$134.67B | -6.4% | — | — | 0.2% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$41.79B | — | — | — | 0.0% |
|
KVUE
Kenvue Inc.
|
$34.19B | +3.8% | -2.1% | — | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CL | -0.7% | -3.7% | +1.1% | -3.7% | +9.4% |
| SPY | -1.2% | -0.4% | +13.1% | -0.4% | +12.1% |
| vs SPY | +0.5% | -3.4% | -12.0% | -3.4% | -2.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.